Moderna secures FDA EUA for its Covid-19 Vaccine mRNA-1273
The company intends to deliver around 20 million doses to the US government by the end of December…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Dec 20
The company intends to deliver around 20 million doses to the US government by the end of December…
18 Dec 20
The FDA approval is based on the positive results of the BLISS-LN study, and the prevalent unmet medical…
18 Dec 20
Riabni is a cytolytic antibody that works similar to Rituxan, with no clinically meaningful differences in safety or…
17 Dec 20
The new cGMP facility in Carlsbad, California would expand the commercialisation of plasmid-based medicines and vaccines
PharmaceuticalsProtein and Peptide Synthesis and Manufacturing
17 Dec 20
The Swiss pharmaceutical firm also secured Rare Pediatric Disease Designation for the treatment of C3 glomerulopathy (C3G)
16 Dec 20
The acquisition will help Lilly establish a gene therapy programme, backed by Prevail's portfolio of neuroscience assets
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Dec 20
The US FDA approval is based on data from the ENSEMBLE PLUS study, in which two-hour Ocrevus infusion…
14 Dec 20
AstraZeneca would generate significant value from the acquisition by expanding Alexion's commercial reach and pipeline development
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Dec 20
Leqvio claimed to be the first and only approved small-interfering RNA (siRNA) low-density lipoprotein cholesterol (LDL-C) lowering treatment…
11 Dec 20
The acquisition will help expand Boehringer Ingelheim’s focus on patients with difficult-to-treat solid tumours